METRO is moving toward the purchase of only zero-emission buses by 2030. Image courtesy of NovaBus

Within the next year or so, you’ll see electric-powered buses buzzing around Bayou City.

The Metropolitan Transit Authority of Harris County (METRO) recently awarded a $22 million contract to Saint-Eustache, Canada-based Nova Bus for the production of 20 battery-powered electric buses. The contract includes an option for another 20 buses.

The first 20 buses, to be manufactured at the Nova Bus factory in Plattsburgh, New York, are expected to be on local roads sometime in in late 2022 or early 2023. They’ll run on the 402 Bellaire Express (Quickline) and 28 OST-Wayside routes.

METRO also plans to test three to five electric buses powered by hydrogen fuel cells. Furthermore, METRO is a member of the Automated Bus Consortium, a national organization of transportation agencies working toward development of a full-size, electric-powered automated bus.

METRO is moving toward the purchase of only zero-emission buses by 2030. It eventually wants to operate more than 1,200 electric buses throughout its system. All types of buses account for 1 percent of transportation-caused greenhouse gases in Houston, according to METRO.

Nova Bus, owned by Swedish automaker Volvo, says its electric vehicles reduce greenhouse gas emissions while also cutting maintenance costs.

“METRO is paying close attention to the climate assessments showing Houston will grapple with rising temperatures and more frequent weather events. It is more critical than ever that METRO map out a plan to not only prepare for these events but to mitigate the impact they have on our community as much as we can,” Carrin Patman, chairwoman of the METRO board, says in a recent presentation.

President Biden has tapped Patman, a Houston attorney, to be the U.S. ambassador to Iceland.

Patman has appointed METRO board members Chris Hollins, former Harris County clerk, and Terry Morales, an executive at Amegy Bank, to shepherd the agency’s efforts to combat climate change.

“The impact of climate change is a significant threat to the health and safety of our community,” Hollins says in the METRO presentation. “METRO can and will be a leader in helping the region respond to this challenge.”

“Beginning with the deployment of clean fleet technology,” he adds, “METRO will lead the way in green transit. METRO is taking a holistic approach — transforming not just our buses, but all our business practices — to increase sustainability, resiliency, and carbon emissions reduction.”

The city of Houston and METRO announced a pilot program that's getting passengers online. Photo via ridemetro.org

METRO announces free Wi-Fi program for select Houston routes

Digital upgrade

METRO is test driving a new feature for its passengers. Select vehicles on a few routes will come with free Wi-Fi on board.

The transportation organization selected the 54 Scott and 204 Spring Park & Ride bus routes and the Green and Purple METRORail lines for the pilot program — in part because of their vicinity to universities and schools, according to a news release from METRO.

"I'm excited we can bring this service to some of our riders. Be it for work, entertainment or personal business, Wi-Fi allows them to stay connected while in transit and improves the overall customer experience," says METRO Board Chair Carrin Patman in the release.

The pilot program, which will run through mid-January, is being funded by $110,220 from the Microsoft Digital Alliance that includes installation and service for over 40 routers. The public-private partnership is also supported by Synnex Corporation, Sierra Wireless, Tracking for Less and AT&T.

"Bringing connectivity to Houston METRO riders is a step forward in the smart city journey, and Microsoft is proud to partner with the city to bring the pilot program to life," says Cameron Carr, director of internet of things strategy, scale and smart city, from Microsoft Corp, in the release.

The announcement is another piece of Mayor Sylvester Turner's Smart City initiative to bring innovation across the city.

"When we first sat down with Microsoft and METRO as part of the Smart City discussions, the first thing we discussed was how can we make the Smart City initiatives inclusive for all residents," says Mayor Turner in the release. "That is why connectivity for everyone, and more efficient public transit was our priority."

Photo via rideMETRO.org

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”